Medicare expands coverage to wigs for cancer and autoimmune patients

What it does

This bill expands Medicare coverage to include wigs (called 'cranial prostheses') as durable medical equipment for patients with hair loss caused by medical conditions like cancer, autoimmune diseases, or chemotherapy. A dermatologist, oncologist, or attending physician must certify in writing that the wig is medically necessary as part of treatment. Medicare will only pay for wigs that meet this certification requirement.

Why we flagged it

The bill's sole operative mechanism is to expand Medicare's definition of covered durable medical equipment to include medically certified wigs (cranial prostheses) for patients with hair loss from serious medical conditions. This is a straightforward benefit expansion with a medical-necessity gate.

What the text implies

• Certification requirement places administrative burden on physicians; practices may need to develop new documentation workflows to comply with Medicare's written-certification mandate.
• Coverage may incentivize manufacturers to market wigs as medical devices rather than cosmetic products, potentially shifting regulatory classification and pricing strategies in the wig industry.
• Scope of 'health condition' causing hair loss is not exhaustively defined; future disputes may arise over whether conditions like alopecia areata, trichotillomania, or other non-cancer hair-loss disorders qualify.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Medicare beneficiaries with hair loss from cancer, chemotherapy, or autoimmune disease gain access to a covered medical device, reducing out-of-pocket costs for a treatment that can improve quality of life and psychological well-being during serious illness. The certification requirement ensures medical appropriateness and prevents frivolous claims.

Who stands to gain

• Medicare beneficiaries (reduced out-of-pocket costs)
• wig manufacturers and suppliers (expanded market access to Medicare reimbursement)

Named in the bill

Medicare, Social Security Act, dermatologists, oncologists, Centers for Medicare & Medicaid Services (CMS)

Where it stands

8 cosponsors: 8 Democrats.

• Feb 12, 2026 — Introduced · Congress.gov: “Introduced in House”
• Feb 12, 2026 — Referred to House Committee on Ways and Means and House Committee on Energy and Commerce · Congress.gov: “Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a…”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.